NDC 0169-2911 – Xultophy 100/3.6
Insulin Degludec 100 [iU]/mL; Liraglutide 3.6 mg/mL · Injection, Solution · Subcutaneous
Product NDC0169-2911
Product details
- Brand name
- Xultophy 100/3.6
- Generic name
- Insulin degludec and liraglutide
- Labeler
- Novo Nordisk
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA208583
- Marketed since
- November 21, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- GLP-1 Receptor Agonist; Insulin Analog
Active ingredients
- Insulin Degludec 100 [iU]/mL
- Liraglutide 3.6 mg/mL
Uses, dosage, side effects and warnings for Xultophy 100/3.6 →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0169-2911-15 | 5 SYRINGE, PLASTIC in 1 CARTON (0169-2911-15) / 3 mL in 1 SYRINGE, PLASTIC | Nov 21, 2016 |
Recalls mentioning this NDC
- D-0623-2021 Apr 21, 2021 · Class I
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and…